Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Methotrexate
•
General Rheumatology
•
Nephrology
At what level of renal impairment do you typically reduce or avoid methotrexate in your rheumatology practice?
Related Questions
What is your approach to methotrexate use (or avoidance) in patients with varying MTHFR mutations?
Do you always get a baseline chest xray in patients who will be starting methotrexate?
How do you approach prescribing analgesics for osteoarthritis related pain in patients with comorbidities, particularly given new evidence that even acetaminophen is associated with increased risk of GI complications (bleeding, peptic ulcer disease), heart failure and CKD?
How would you advise a CKD patient who asks about oral NSAIDs for management of chronic pain if they have a contraindication to taking acetaminophen?
What is your approach to diagnosing and managing methotrexate-induced alopecia?
How would you approach management of retroperitoneal fibrosis causing ureteral compression that has already caused irreversible loss of kidney function?
How do you approach the significance of +RNP III antibody in a patient with positive ANA but no other signs or symptoms of systemic sclerosis?
Is there any value to IgG subclasses in assessing immune deficiency in a patient with normal IgG levels?
What additional workup would you perform to evaluate a new onset of spontaneous hemarthrosis?
Is transdermal estrogen therapy safe for postmenopausal patients with positive antiphospholipid antibodies but no history of thrombosis or obstetric complications?
